Mill Creek Capital Advisors LLC lowered its holdings in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 2.8% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 108,944 shares of the company's stock after selling 3,136 shares during the quarter. Procter & Gamble accounts for about 0.4% of Mill Creek Capital Advisors LLC's investment portfolio, making the stock its 24th biggest position. Mill Creek Capital Advisors LLC's holdings in Procter & Gamble were worth $18,566,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Northern Trust Corp grew its stake in Procter & Gamble by 10.1% during the fourth quarter. Northern Trust Corp now owns 29,395,208 shares of the company's stock worth $4,928,107,000 after buying an additional 2,703,757 shares during the last quarter. Goldman Sachs Group Inc. grew its stake in shares of Procter & Gamble by 3.5% during the first quarter. Goldman Sachs Group Inc. now owns 17,405,539 shares of the company's stock valued at $2,966,252,000 after purchasing an additional 583,629 shares during the last quarter. Charles Schwab Investment Management Inc. grew its stake in shares of Procter & Gamble by 1.2% during the first quarter. Charles Schwab Investment Management Inc. now owns 17,090,898 shares of the company's stock valued at $2,911,989,000 after purchasing an additional 208,991 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in shares of Procter & Gamble by 15.8% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 16,274,563 shares of the company's stock valued at $2,728,430,000 after purchasing an additional 2,224,912 shares during the last quarter. Finally, Invesco Ltd. grew its stake in shares of Procter & Gamble by 19.8% during the first quarter. Invesco Ltd. now owns 13,493,604 shares of the company's stock valued at $2,299,580,000 after purchasing an additional 2,228,151 shares during the last quarter. Institutional investors own 65.77% of the company's stock.
Procter & Gamble Trading Up 0.4%
PG opened at $154.30 on Friday. The stock has a market capitalization of $361.43 billion, a P/E ratio of 23.70, a P/E/G ratio of 4.07 and a beta of 0.37. Procter & Gamble Company has a 12 month low of $149.91 and a 12 month high of $180.43. The firm's fifty day simple moving average is $157.19 and its 200 day simple moving average is $163.27. The company has a current ratio of 0.70, a quick ratio of 0.49 and a debt-to-equity ratio of 0.49.
Procter & Gamble (NYSE:PG - Get Free Report) last posted its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 EPS for the quarter, beating the consensus estimate of $1.42 by $0.06. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The business had revenue of $20.89 billion for the quarter, compared to analysts' expectations of $20.79 billion. During the same period in the previous year, the firm posted $1.40 EPS. The firm's revenue was up 1.7% compared to the same quarter last year. As a group, research analysts anticipate that Procter & Gamble Company will post 6.91 EPS for the current fiscal year.
Procter & Gamble Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Friday, July 18th were paid a $1.0568 dividend. This represents a $4.23 annualized dividend and a yield of 2.7%. The ex-dividend date was Friday, July 18th. Procter & Gamble's payout ratio is presently 64.98%.
Analyst Upgrades and Downgrades
A number of brokerages have issued reports on PG. Piper Sandler raised their price objective on shares of Procter & Gamble from $160.00 to $164.00 and gave the company a "neutral" rating in a research note on Monday, May 5th. Truist Financial reduced their price objective on shares of Procter & Gamble from $185.00 to $180.00 and set a "buy" rating on the stock in a research note on Friday, April 25th. Evercore ISI reaffirmed an "in-line" rating and issued a $170.00 price objective (down from $190.00) on shares of Procter & Gamble in a research note on Monday, July 14th. JPMorgan Chase & Co. reaffirmed a "neutral" rating and issued a $170.00 price objective (down from $178.00) on shares of Procter & Gamble in a research note on Friday, July 25th. Finally, Morgan Stanley set a $180.00 price objective on shares of Procter & Gamble and gave the company an "overweight" rating in a research note on Friday, April 25th. Seven equities research analysts have rated the stock with a hold rating, eleven have issued a buy rating and two have issued a strong buy rating to the company's stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $175.94.
View Our Latest Stock Report on Procter & Gamble
Procter & Gamble Company Profile
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Further Reading
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.